Updates from around the Mölnlycke world
Collaboration is key to our success. Explore what we’re saying, what we’re sharing and what we’re thinking.
February 21, 2021
JWC Awards 21-26 February
The Journal of Wound Care (JWC) is proud to announce the 2nd JWC WUWHS awards, celebrating achievements made in the four years since the last 2016 award...
January 31, 2021
Wounds Week 1-5 February
With 5 days of incredibly current topics, Wounds Week gives a chance for the wound care community to come together in these difficult times and engage i...
Statement on our Supplier Code of Conduct
Mölnlycke has recently been made aware of alleged deviations from our Supplier Code of Conduct by one of our Chinese suppliers. We take these reports ve...
Mölnlycke boosts customer supply route with new UK distribution centre
7 December 2020, Milton Keynes, UK. Mölnlycke announces the launch of a new UK distribution centre, strengthening customers’ access to quality Mölnlycke...
December 9, 2020
Diabetic foot Europe 2020
Diabetic foot complications are among the most serious complications from diabetes – which is growing at an epidemic rate in both developed and developi...
Successful 10-year Eurobond issue for Mölnlycke
Mölnlycke, a world-leading medical solutions company, successfully launched on 2 of December a EUR 400 million senior unsecured bond under its EMTN (Eur...
Zlatko Rihter assumes position as President and CEO of Mölnlycke
Today, Zlatko Rihter assumes his position as President and CEO of Mölnlycke.
Welcome to WoundCon autumn edition
WoundCon is returning with new speakers, new topics and new exhibitors. Join Mölnlycke ® for a virtual day full of education, networking, clinical...
Re-opening Operating Theatres: Navigating the post Covid-19 elective surgery backlog
Welcome to our popular Mölnlycke Talks Online - 'Re-opening Operating Theatres: Navigating the post Covid-19 elective surgery backlog. December 1, 19:00...
Pressure injury challenges in a new era
Pressure injuries (PI) continue to present substantial clinical challenges to health care professionals and place a huge economic burden on health care...
Mölnlycke launches new skin-friendly Biogel® surgical gloves to reduce the risk of allergic contact dermatitis for surgeons and nurses
Gothenburg, Sweden. 15 October, 2020 – Mölnlycke is celebrating World Handwashing Day with the global launch of the innovative Biogel® PI UltraTouch® S...
November 23, 2020
Covid: a catalyst to improve patient engagement. Rethink wound care
Welcome to our popular Mölnlycke Talks Online - 'Covid: a catalyst to improve patient engagement. Rethink wound care'. November 23, 7:00PM CET.
November 18, 2020
EWMA Virtual Wound Conference 2020
Join us for the European Wound Management Association (EWMA) Virtual 2020 on November 18 - 19. The theme is Enhancing Wound Care Quality: Global...
Send a smile with Mölnlycke card
On World Smile Day, 2 October, in collaboration with our global charity Operation Smile, we are encouraging our employees, partners and customers to sen...
One third of surgeons and nurses experience harmful allergic reactions in the operating theatre
24 September 2020: With surgeons and nurses working to clear the elective backlog from coronavirus, a new global survey has revealed they are suffering...
September 24, 2020
EPUAP virtual event
Let's meet at the European Pressure Ulcer Advisory Panel's (EPUAP) virtual event on September 24, 2020. The meeting focuses on the theme: '2020 – THE MO...
September 18, 2020
DFSG Virtual meeting 2020
Join Mölnlycke at the Diabetic Foot Study Group (DFSG's) virtual meeting on September 18 - 19, 2020. On Friday, September 18, Professor Paul Chadwick...
September 13, 2020
Welcome to WUWHS Online 2020
Join us at the World Union of Wound Healing Societies (WUWHS) Online Event from September 13 - 17, 2020. From September 13, the WUWHS online event...
Barry McBride to take on the position as interim CEO
Gothenburg – 24 July 2020 Barry McBride, EVP Gloves, Antiseptics and Global R&D, will take on the role as interim CEO as of 1 August and until the new...
July 17, 2020
Welcome to WoundCon 2020
Join us at WoundCon on July 17, 2020. What has kept us energised throughout th is challenging time is finding ways to reach out to and support our ...
AstraZeneca’s BioVentureHub and Mölnlycke collaborate to support knowledge exchange across the Swedish life science industry
AstraZeneca’s BioVentureHub announced today that it has established a new collaboration with Mölnlycke, a global medtech company headquartered in...
June 22, 2020
Mölnlycke Talks Online
Welcome to our popular Mölnlycke Talks, now online! Optimising wound care through patient engagement. 22 June 2020, 19.00 CEST
March 17, 2020
How we handle the Covid-19 situation
Being a provider of medical devices for health care professionals – many of which are critically needed to combat the evolving COVID-19 situation –...
May 29, 2020
Zlatko Rihter appointed new CEO of Mölnlycke
Zlatko Rihter has been appointed President and CEO of the medical solutions company, Mölnlycke Health Care AB.
Medical Device Regulation (MDR) to be postponed
The Medical Device Regulation (MDR) – which was due to enter into force in May this year –will replace the Medical Device Directive in Europe and is muc...
Mölnlycke employees volunteering at the front line
Mölnlycke takes pride in having a highly trained workforce as many of our employees have a clinical background.
Mölnlycke supplies Swedish National Board of Health and Welfare with additional 12 million face masks
By utilising its extensive global supplier network, the world-leading medical solutions company, Mölnlycke has managed to contract suppliers for...
French export ban for face masks lifted
Thanks to crucial efforts by the Swedish Prime Minister Stefan Löfven and several other parties, the French government has today decided to lift the...
CEO Richard Twomey leaves Mölnlycke
Richard Twomey, President and CEO of Mölnlycke, will after six years leave the organisation.
New cost benefit analysis reports NHS chronic wound care costs can be reduced by use of haemoglobin spray
New report shows Granulox ® (Mölnlycke), an innovative topical haemoglobin spray, is a cost-effective therapy in chronic wound care management as adjunc...
Mölnlycke appoints new Chief Financial Officer
With a strong track record of financial leadership in publicly listed Swedish companies Susanne Larsson will join the company as Group Chief Financial...
More than 9 in 10 surgeons encounter a needlestick injury
Global s urvey of 510 surgeons is first of its kind ; 81% believe high quality gloves impact patient outcomes ; 92% agree d that high...
Successful EMTN programme establishment and 10-year Eurobond issue for Mölnlycke
Mölnlycke, a world-leading medical solutions company, successfully launched on 28 August a EUR 500 million senior unsecured bond off its newly establish...
Thousands of diabetic foot ulcer patients could benefit from topical oxygen therapy with updated treatment pathway
Mölnlycke and Zuellig Pharma strengthen partnership for advanced wound care solutions in South-East Asia
The partnership will leverage deep expertise of both companies to improve range and availability of wound care products and solutions across the region
Mölnlycke acquires invention to help detect infection
How can innovation help detect wound infection and possibly reduce unnecessary use of antibiotics in wound care? Watch as R&D director Anders Dahlberg...
Mölnlycke acquires patent for smart solutions to detect infection in wounds
The Swedish medical solutions company, Mölnlycke, is acquiring a patent application from Innovation Skåne, that will help detect infections in wounds....
Introducing Healthcare Intelligence
What will healthcare look like in the next 10 years? What will it look like next year?
January 1, 2019
Mölnlycke acquires M&J Airlaid Products A/S to further strengthening its wound care capabilities
Mölnlycke, a world-leading medical products and solutions company, is pleased to announce its acquisition of M&J Airlaid Products A/S (“M&J”).
August 10, 2018
Mölnlycke at IFSO 2018 Dubai
From 26-29 September 2018, Mölnlycke was present at the 23rd World Congress of the International Federation for the Surgery of Obesity and Metabolic...
Mölnlycke acquires German wound care company SastoMed GmbH
The world-leading medical solutions company, Mölnlycke, has acquired German wound care products company, SastoMed GmbH. The deal adds new, award-winning...
Creating opportunities at AZ BioVenture Hub
Just a few months since Mölnlycke signed a partnership with AstraZeneca BioVenture Hub, and it has already resulted in collaboration and building...
Viktiga produktlanseringar under andra kvartalet
Mölnlyckes försäljning växte under årets andra kvartal med 1 % i konstant valuta. Såväl Wound Care som Surgical växte, dock med en lägre tillväxttakt än...
Mölnlycke Holding AB (publ) EUR 350,000,000 Revolving Credit Facility
We are pleased to announce the successful closing and signing of a EUR 350,000,000 Multicurrency Revolving Credit Facility (the “Facility”) for Mölnlyck...
Media & Press
Our press room
In our press room you can find the latest press releases as well as our logotype and images for download.